Schizophrenia Clinical Trials

Showing 21-40 of 1,356 trials

THE EFFECTS OF AN ONLINE FAMILY PSYCHOEDUCATION PROGRAM ON EXPRESSED EMOTION OF FAMILY MEMBERS AND MEDICATION ADHERENCE OF PATIENTS WITH FIRST-EPISODE SCHIZOPHRENIA

NCT07545941

This study examined the effects of family psychoeducation program via line application on expressed emotion of family members and medication adherence in patients with first-episode schizophrenia.

First- Episode Schizophrenia

Mahidol University53 participantsStarted May 2025

Bangkok Noi, Bangkok, Thailand

COMPLETEDNA

Efficacy of Pediococcus Acidilactici as add-on to Antipsychotic Drugs on Metabolic Syndrome Disturbances in First-episode Psychosis and Schizophrenia Spectrum Disorders.

NCT07371325

The aim of the present study is to evaluate the effectiveness of the addition of the postbiotic Pediococcus acidilactici (pA1c®HI) on amelioration of metabolic disturbances in patients with (FEP) or (SSD) treated with antipsychotic drugs.

SCHIZOPHRENIA 1 (Disorder)Metabolic AbnormalitiesPostbiotic Supplement

Manuel Jesús Cuesta Zurita36 participantsStarted Sep 2024

Pamplona, Navarre, Spain

THE EFFECTS OF AN ONLINE FAMILY PSYCHOEDUCATION PROGRAM ON EXPRESSED EMOTION OF FAMILY MEMBERS AND MEDICATION ADHERENCE OF PATIENTS WITH FIRST-EPISODE SCHIZOPHRENIA

Efficacy of Pediococcus Acidilactici as add-on to Antipsychotic Drugs on Metabolic Syndrome Disturbances in First-episode Psychosis and Schizophrenia Spectrum Disorders.

Related Searches

Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine

Synbiotic Compound to Reduce Symptoms of Schizophrenia

Acceptability and Efficacy of Group Reminiscence Intervention in a Sample of Patients With Schizophrenia

Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component

Theta-burst rTMS in Schizophrenia to Ameliorate Negative and Cognitive Symptoms

Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization

Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer

Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia

Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia

Peer-led Psycho-education for Schizophrenia

Cognitive Effects of tDCS and tRNS in Schizophrenia

Arts-based Social Prescribing for Mental Health

ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention

Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients

TIS for Improving Cognitive Impairment Associated With Schizophrenia

Lifestyle MIND- Feasibility of Wait-list Control

Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder

An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia